ES8605975A1 - Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas - Google Patents

Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas

Info

Publication number
ES8605975A1
ES8605975A1 ES539500A ES539500A ES8605975A1 ES 8605975 A1 ES8605975 A1 ES 8605975A1 ES 539500 A ES539500 A ES 539500A ES 539500 A ES539500 A ES 539500A ES 8605975 A1 ES8605975 A1 ES 8605975A1
Authority
ES
Spain
Prior art keywords
controlled release
liquid dosage
pharmaceuticals
approximately
dosage formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539500A
Other languages
English (en)
Spanish (es)
Other versions
ES539500A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Development Corp
Original Assignee
Battelle Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Development Corp filed Critical Battelle Development Corp
Publication of ES539500A0 publication Critical patent/ES539500A0/es
Publication of ES8605975A1 publication Critical patent/ES8605975A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES539500A 1984-01-13 1985-01-11 Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas Expired ES8605975A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57046984A 1984-01-13 1984-01-13

Publications (2)

Publication Number Publication Date
ES539500A0 ES539500A0 (es) 1986-04-01
ES8605975A1 true ES8605975A1 (es) 1986-04-01

Family

ID=24279767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539500A Expired ES8605975A1 (es) 1984-01-13 1985-01-11 Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas

Country Status (11)

Country Link
EP (1) EP0169236A1 (OSRAM)
JP (1) JPS61500910A (OSRAM)
AU (1) AU3835885A (OSRAM)
CA (1) CA1239347A (OSRAM)
ES (1) ES8605975A1 (OSRAM)
GR (1) GR850069B (OSRAM)
IL (1) IL74049A0 (OSRAM)
IT (1) IT1184309B (OSRAM)
NZ (1) NZ210785A (OSRAM)
WO (1) WO1985003000A1 (OSRAM)
ZA (1) ZA85239B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE109659T1 (de) * 1986-03-21 1994-08-15 Eurasiam Lab Arzneimittelzusammensetzungen.
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
IT1226940B (it) * 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
KR100259989B1 (ko) * 1991-10-01 2000-08-01 모리다 가쓰라 서방성 마이크로캡슐 제제 및 그의 제조법
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
AU4198793A (en) 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
ATE288257T1 (de) 1999-04-06 2005-02-15 Ethypharm Sa Trinkbare pharmazeutische suspension von ibuprofen
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
WO2004096175A2 (en) * 2003-04-30 2004-11-11 Ranbaxy Laboratories Limited Taste masked microcapsules and processes for their preparation
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation

Also Published As

Publication number Publication date
EP0169236A1 (en) 1986-01-29
NZ210785A (en) 1987-11-27
IL74049A0 (en) 1985-04-30
IT1184309B (it) 1987-10-28
ES539500A0 (es) 1986-04-01
JPS61500910A (ja) 1986-05-08
GR850069B (OSRAM) 1985-05-03
ZA85239B (en) 1985-08-28
AU3835885A (en) 1985-07-30
WO1985003000A1 (en) 1985-07-18
IT8519086A0 (it) 1985-01-11
CA1239347A (en) 1988-07-19

Similar Documents

Publication Publication Date Title
ES8605975A1 (es) Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas
CA2086847A1 (en) Stable, liquid products containing fat-soluble substances
AU586286B2 (en) Pharmaceutical and dietary composition
AU4709989A (en) Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product
AU1785483A (en) Slow release and fast release tablet formulation comprising two active ingredients
CA2016039A1 (en) Extended release pharmaceutical formulations
AU588968B2 (en) Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
ES8500561A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas dermicas de accion prolongada y continua a base de acidos grasos esenciales
CA2045290A1 (en) Plaster with a high content of softening ingredients
HK22396A (en) Pharmaceutical composition containing felbinac
AU4034885A (en) Pyridazine derivatives
CA2069433A1 (en) Antiperspirant
IE810036L (en) Sustained release compositions
EP0208519A3 (en) Solubilized composition of hardly-soluble pharmaceutical product
NO962129L (no) Ny farmasöytisk blanding for fremstilling av et stabilt pulver inneholdende et aktivt prinsipp omfattende en forbindelse av acetylsalicylsyre og metoklopramid
CA2046216A1 (en) Coating composition for glass containers
CA2128103A1 (en) Formulation and use of carotenoids in treatment of cancer
IL65922A0 (en) Preparation of apovincaminic acid esters,certain novel optically active derivatives thereof and pharmaceutical compositions containing them
US5200428A (en) Agent for the tsh suppression and treatment of struma
CA2015632A1 (en) Stable solutions of rebeccamycin analog and preparations thereof
HUT37865A (en) Pesticide compositions containing derivatives of alkane-,alkene- or alkadiene-carboxylic acid amides as active substances and process for preparing the active substances
JPS57134414A (en) Preparation of sugar-coated tablet
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
AU578104B2 (en) Pharmaceutical composition of peroxydiphosphoric acid derivatives
DE3162067D1 (en) Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions